Effect of norepinephrine on uterine contraction during cesarean section: a randomized, double-blind, controlled study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030884

Enrollment

Unknown

Registered

2020-03-16

Start date

2020-03-12

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

control group:Normal saline

experimental group:norepinephrine

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA statue of I or II, patients with a single pregnancy, at full-term (gestational aged >= 37 weeks).

Exclusion criteria

Exclusion criteria: Obesity (body mass index, BMI > 35 kg/m2), active labor, early labor, diabetes mellitus or gestational diabetes, hypertension or pre-eclampsia, intrauterine growth restriction or fetal macrosomia, placenta previa, placenta conglutination, placenta implantation, significant co-existing maternal disease, any absolute contraindications to spinal or epidural anesthesia such as local infection or bleeding disorders.

Design outcomes

Primary

Measure	Time frame
dose of oxytocin;loss of blood;	—

Countries

China

Contacts

Public ContactXiao Fei

13706597501@163.com+86 13706597501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026